Hematology/Oncology

Top Story

Malignant pheochromocytomas harbor a variety of genomic alterations

February 17, 2019
Meeting News

Immunotherapy 'tidal wave' demands interdisciplinary approach

February 16, 2019
SCOTTSDALE, Ariz. — In the face of the “tidal wave of cancer immunotherapy,” collaboration across disciplines is required to manage immune-related…
Meeting News

Retroperitoneal lymph node dissection demonstrates ‘excellent’ survival rates for testicular seminoma

February 16, 2019
SAN FRANCISCO — Retroperitoneal lymph node dissection conferred favorable survival rates among men with testicular seminoma used as first-line therapy or following…
Meeting News

Penile squamous cell carcinoma may benefit from therapies used in HPV-related cancers

February 15, 2019
SAN FRANCISCO — Characterization of genomic alterations in penile squamous cell carcinoma revealed involvement of multiple cancer genes that likely contribute to…
Meeting News

Sacituzumab govitecan response rates 'promising' in metastatic urothelial cancer

February 15, 2019
SAN FRANCISCO – Sacituzumab govitecan showed activity in patients with relapsed or refractory
More Headlines »
CME CNE CPE

Advances in the Management of Toxicities Associated with Stem Cell Transplant

This activity is supported by an educational grant from Cumberland Pharmaceuticals.

Therapeutic options for the treatment of multiple myeloma continue to evolve. Currently, high-dose melphalan followed…
More »
Video
Meeting News

VIDEO: Ibrutinib-rituximab prolongs PFS, OS in chronic lymphocytic leukemia

January 26, 2019
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next